Drug Delivery Systems in Urology--getting "smarter"

Overview

Journal Urology

Specialty Urology

Date 2006 Oct 3

PMID 17010721

Citations 8

Authors

Omid C Farokhzad

Jordan D Dimitrakov

Jeffrey M Karp

Ali Khademhosseini

Michael R Freeman

Robert Langer

Affiliations

Soon will be listed here.

Citing Articles

Insights into the Safety and Versatility of 4D Printed Intravesical Drug Delivery Systems.

Uboldi M, Perrotta C, Moscheni C, Zecchini S, Napoli A, Castiglioni C Pharmaceutics. 2023; 15(3).

PMID: 36986618 PMC: 10057729. DOI: 10.3390/pharmaceutics15030757.

Otorhinolaryngological adverse effects of urological drugs.

Maia N, Lopes K, Gananca F Int Braz J Urol. 2021; 47(4):747-752.

PMID: 33566468 PMC: 8321485. DOI: 10.1590/S1677-5538.IBJU.2021.99.06.

Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells.

Rodriguez-Ruiz V, Maksimenko A, Salzano G, Lampropoulou M, Lazarou Y, Agostoni V Sci Rep. 2017; 7(1):8353.

PMID: 28827534 PMC: 5566897. DOI: 10.1038/s41598-017-08727-y.

Safety and efficacy of Intraurethral Mitomycin C Hydrogel for prevention of post-traumatic anterior urethral stricture recurrence after internal urethrotomy.

Moradi M, Derakhshandeh K, Karimian B, Fasihi M J Inj Violence Res. 2016; 8(2):75-9.

PMID: 27093204 PMC: 4967365. DOI: 10.5249/jivr.v8i2.812.

Advances in intravesical therapy for urinary tract disorders.

Tyagi P, Kashyap M, Hensley H, Yoshimura N Expert Opin Drug Deliv. 2015; 13(1):71-84.

PMID: 26479968 PMC: 4955766. DOI: 10.1517/17425247.2016.1100166.

References

Ferrari M . Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005; 5(3):161-71. DOI: 10.1038/nrc1566. View

Grayson A, Voskerician G, Lynn A, Anderson J, Cima M, Langer R . Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. J Biomater Sci Polym Ed. 2004; 15(10):1281-304. DOI: 10.1163/1568562041959991. View

Wientjes M, Zheng J, Hu L, Gan Y, Au J . Intraprostatic chemotherapy: distribution and transport mechanisms. Clin Cancer Res. 2005; 11(11):4204-11. DOI: 10.1158/1078-0432.CCR-04-1969. View

Bander N, Milowsky M, Nanus D, Kostakoglu L, Vallabhajosula S, Goldsmith S . Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. J Clin Oncol. 2005; 23(21):4591-601. DOI: 10.1200/JCO.2005.05.160. View

Ramakumar S, Phull H, Purves T, Funk J, Copeland D, Ulreich J . Novel delivery of oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy model. J Urol. 2005; 174(3):1133-6. DOI: 10.1097/01.ju.0000168617.17080.46. View

Farokhzad O, Khademhosseini A, Jon S, Hermmann A, Cheng J, Chin C . Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem. 2005; 77(17):5453-9. DOI: 10.1021/ac050312q. View

Li Y, Ho Duc H, Tyler B, Williams T, Tupper M, Langer R . In vivo delivery of BCNU from a MEMS device to a tumor model. J Control Release. 2005; 106(1-2):138-45. DOI: 10.1016/j.jconrel.2005.04.009. View

Bartoletti R, Cai T, Gacci M, Giubilei G, Viggiani F, Santelli G . Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study. Urology. 2005; 66(4):726-31. DOI: 10.1016/j.urology.2005.04.062. View

Dineen M, Tierney D, Kuzma P, Pentikis H . An evaluation of the pharmacokinetics and pharmacodynamics of the histrelin implant for the palliative treatment of prostate cancer. J Clin Pharmacol. 2005; 45(11):1245-9. DOI: 10.1177/0091270005281043. View

10.

Venkatraman S, Tan L, Joso J, Boey Y, Wang X . Biodegradable stents with elastic memory. Biomaterials. 2005; 27(8):1573-8. DOI: 10.1016/j.biomaterials.2005.09.002. View

11.

Podual K, Doyle 3rd F, Peppas N . Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly(ethylene glycol) grafts. J Control Release. 2000; 67(1):9-17. DOI: 10.1016/s0168-3659(00)00195-4. View

12.

Santini Jr J, Richards A, Scheidt R, Cima M, Langer R . Microchip technology in drug delivery. Ann Med. 2000; 32(6):377-9. DOI: 10.3109/07853890008995941. View

13.

Hicke B, Stephens A . Escort aptamers: a delivery service for diagnosis and therapy. J Clin Invest. 2000; 106(8):923-8. PMC: 314349. DOI: 10.1172/JCI11324. View

14.

White R, Sullenger B, Rusconi C . Developing aptamers into therapeutics. J Clin Invest. 2000; 106(8):929-34. PMC: 314350. DOI: 10.1172/JCI11325. View

15.

Au J, Badalament R, Wientjes M, Young D, Warner J, Venema P . Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. J Natl Cancer Inst. 2001; 93(8):597-604. DOI: 10.1093/jnci/93.8.597. View

16.

Blank M, Weinschenk T, Priemer M, Schluesener H . Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J Biol Chem. 2001; 276(19):16464-8. DOI: 10.1074/jbc.M100347200. View

17.

Whitesides G, Ostuni E, Takayama S, Jiang X, Ingber D . Soft lithography in biology and biochemistry. Annu Rev Biomed Eng. 2001; 3:335-73. DOI: 10.1146/annurev.bioeng.3.1.335. View

18.

Chovan T, Guttman A . Microfabricated devices in biotechnology and biochemical processing. Trends Biotechnol. 2002; 20(3):116-22. DOI: 10.1016/s0167-7799(02)01905-4. View

19.

Morishita M, Lowman A, Takayama K, Nagai T, Peppas N . Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release. 2002; 81(1-2):25-32. PMC: 4467766. DOI: 10.1016/s0168-3659(02)00019-6. View

20.

Lendlein A, Langer R . Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science. 2002; 296(5573):1673-6. DOI: 10.1126/science.1066102. View